Wei-Ting Chen, M.D. 陳偉挺醫師

Email / Blog / LinkedInFacebook / 進擊的黴菌:黴菌感染討論區

Current positions

2018/12 - present
亞太區醫藥學術處長, 美商默沙東藥廠 
Asia Pacific Regional Director of Medical Affairs, 
Infectious Diseases,

2017/10 - present
兼任感染科主治醫師, 和信治癌中心醫院 
Adjunct Attending Physician, Division of Infectious Diseases,
Koo Foundation Sun Yat-Sen Cancer Center (KFSYSCC), Taiwan

2015 - present
講師, 簡報架構與視覺設計工作坊, 新思惟國際
Instructor, Structure and visual design of a great presentation workshop,
InnovaRad, Taiwan

Work experience

2018/08 - 2018/11
亞太區代理醫藥學術處長, 美商默沙東藥廠 
Interim Asia Pacific Regional Director of Medical Affairs,
Antifungal / C. difficile infection  / Cytomegalovirus,
Merck Sharp & Dohme

2017/10 - 2018/11
資深醫藥顧問, 美商默沙東藥廠 
Senior Medical Advisor, Hospital Acute Care & Vaccines,
Merck Sharp & Dohme (I.A.) LLC, Taiwan Branch

2015/01 - 2017/09
資深感染科主治醫師, 和信治癌中心醫院
Senior Attending Physician, Division of Infectious Diseases, KFSYSCC, Taiwan

2009/07 - 2014/12
感染科主治醫師, 和信治癌中心醫院
Attending Physician, Division of Infectious Diseases, KFSYSCC, Taiwan


2016 - 2017
數位諮詢委員, 輝瑞大藥廠

Education and Training

2007 – 2009
台大醫院 感染科專研醫師
ID fellowship, National Taiwan University Hospital, Taipei, Taiwan

2004 – 2007
和信治癌中心醫院 內科住院醫師
Medicine residency, Koo Foundation Sun Yat-Sen Cancer Center, Taipei, Taiwan

2003 – 2004
高雄榮民總醫院 實習醫師
Internship, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan

1997 – 2004
School of Medicine, National Yang Ming University, Taipei, Taiwan

Honors, Scholarship and Grants


2010 Resident Scientific Manuscript Award, the Infectious Diseases Society of Taiwan
2009 ID Fellows Grant Program, 49th ICAAC, San Francisco, CA
2008 Fellow Travel Grant, 48th ICAAC / 46th IDSA, Washington, DC
2004 Best intern, Kaohsiung Veterans General Hospital
2003 Andrew T. Huang Medical Education Promotion Scholarship
2003 Duke University Medical Center Visiting Student


2016 新思惟「醫學演講大賽」得獎
2015 新思惟「醫學簡報設計大賽」得獎
2015 新思惟「存活曲線大賽」得獎


Invasive fungal diseases

1. Ko BS, Chen WT, Kung HC, Wu UI, Tang JL, Yao M, Chen YC, Tien HF, Chang SC, Chuang YC, Lin DT. 2016 Guideline Strategies for the use of antifungal agents in patients with hematological malignancies or hematopoietic stem cell transplantation recipients in Taiwan. J Microbiol Immunol Infect 2017.

2. Kung HC, Huang PY, Chen WT, Ko BS, Chen YC, Chang SC, Chuang YC. 2016 Guidelines for the use of antifungal agents in patients with invasive fungal diseases in Taiwan. J Microbiol Immunol Infect 2017.

3. Yang XY, Chen WTBurden of invasive mold disease in patients with acute myelogenous leukemia and in stem cell transplant recipients. J Microbiol Immunol Infect 2017.

4. Liu JY, Chen WT, Ko BS, Yao M, Hsueh PR, Hsiao CH, Kuo YM, Chen YC. Combination antifungal therapy for disseminated fusariosis in immunocompromised patients: a case report and literature review. Med Mycol 2011.

Hematology and stem cell transplantation

1. Fang LH, Shih LS, Lee PI, Chen WT, Chen RL. Mediastinal germ cell tumor-associated histiocytic proliferations treated with thalidomide plus chemotherapy followed by alemtuzumab-containing reduced intensity allogeneic peripheral blood stem cell transplantation: a case report. Medicine 2016.

2. Liu WH, Chen WT, Fang LH, Chen RL. Idiopathic pneumonia syndrome and thrombotic microangiopathy following nonmyeloablative haploidentical peripheral blood stem cell transplantation and post-transplant cyclophosphamide: a case report. Medicine 2015.

3. Chen WT, Fang LH, Chen RL. Long-term cancer-free survival after infusion of autologous cord blood cells for rejection-unrelated cord blood graft after myeloablative conditioning for t-MDS. Medicine 2015.

Catheter-related infections

1. Chen WT, Huang HR, Lim KP, Tseng HC, Shih CC. The correlation between seasonality and peripherally inserted central catheter-related infections in cancer patients. J Infect 2015.

2. Chen WT, Wang CY, Huang HR, Tseng HC, Shih CC. Reducing catheter-related bloodstream infection by implementing hospital-wide central venous catheter bundle at a cancer hospital. J Microbiol Immunol Infect 2015.

3. Chen WT, Tseng HC, Shih CC. Approximately 17% of catheterized cancer patients with non-catheter-related bacteraemia have positive differential time. J Hosp Infect 2011.

4. Chen WT, Liu TM, Wu SH, Tan TD, Tseng HC, Shih CC. Improving diagnosis of central venous catheter-related bloodstream infection by using differential time to positivity as a hospital-wide approach at a cancer hospital. J Infect 2009.


1. Chen GC, Pan SC, Foo J, Morel C, Chen WT, Wang JT. Comparing ceftolozane/tazobactam versus piperacillin/tazobactam as empiric therapy for complicated urinary tract infection in Taiwan: a cost-utility model focusing on gram-negative bacteria. J Microbiol Immunol Infect 2019.

2. Chi CY, Lin CH, Ho MW, Ding JY, Huang WC, Shih HP, Yeh CF, Fung CP, Sun HY, Huang CT, Wu TS, Chang CY, Liu YM, Feng JY, Wu WK, Wang LS, Tsai CH, Ho CM, Lin HS, Chen HJ, Lin PC, Liao WC, Chen WT, Lo CC, Wang SY, Kuo CY, Lee CH, Ku CL. Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-γ autoantibodies and disseminated nontuberculous mycobacterial infections. Medicine 2016.

3. Chen WT, Wang JT, Lee WS, Huang CH, Liao CH, Chen YC, Chang SC. Performance of the BD GeneOhm Methicillin-resistant Staphylococcus aureus (MRSA) PCR assay for detecting MRSA nasal colonization in Taiwanese adults. J Microbiol Immunol Infect 2010.

4. Tarng DC, Tsai TJ, Chen WT, Liu TY, Wei YH. Effect of human OGG1 1245C-->G gene polymorphism on 8-hydroxy-2'-deoxyguanosine levels of leukocyte DNA among patients undergoing chronic hemodialysis. J Am Soc Nephrol 2001.